Client-Pharma
Client-Pharma is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients with Nectin-4 Expressing Advanced Malignancies.
Sponsor Bicycletx Limited
- Start (EU)
- Latest update
- Estimated end
A Phase 3 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants with Chronic HDV Infection Not Virologically Suppressed with Bulevirtide (ECLIPSE 2)
Sponsor Vir Biotechnology Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants with Chronic HDV Infection (ECLIPSE 1)
Sponsor Vir Biotechnology Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Client-Pharma?
The 2026-10-09 snapshot links Client-Pharma to 3 distinct CTIS trials. Recorded services include Commercial drug sourcing, Water for injection vendor, Water for injection vendor for Romania. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Client-Pharma?
The most frequently recorded therapeutic areas are Gastroenterology, Gynecology, Otolaryngology, Solid Tumor Oncology. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Client-Pharma conducted?
The linked trials record locations in 6 countries, including France, Germany, Spain, Italy, Romania. These are trial locations, not confirmed office locations or countries where Client-Pharma delivered services.
What can this page tell me about Client-Pharma's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Client-Pharma. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Client-Pharma Limited